Physician
Boyce & Bynum Pathology Professional Services INC
Boyce & Bynum Pathology Professional Services INC was paid $1.08M by Medicaid between Jan 2018 and Dec 2024, across 15 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 61% of everything it billed.
33Billing provider infoBOYCE & BYNUM PATHOLOGY PROFESSIONAL SERVICES INC
COLUMBIA, MO 65201
COLUMBIA, MO 65201
33aNPI1689634818assigned 03/23/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.08M
24GClaims34,636
24DCodes billed15
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Missouri
Rank by total paid#3 of 103
Median peer was paid$15K
This provider vs. median74×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,076 | $50K | |
| 2019 | 1,849 | $40K | |
| 2020 | 4,447 | $163K | |
| 2021 | 9,547 | $319K | |
| 2022 | 5,817 | $158K | |
| 2023 | 6,449 | $198K | |
| 2024incomplete | 4,451 | $150K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 61% | 22,792 | 17,722 | $663K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 24% | 4,506 | 1,063 | $256K |
| 88307 | 4.5% | 726 | 643 | $48K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.5% | 2,585 | 735 | $48K |
| 88342 | 2.5% | 1,313 | 987 | $27K | |
| 88312 | 1.6% | 1,061 | 897 | $17K | |
| 88304 | 1.1% | 1,339 | 1,194 | $12K | |
| 88341 | <1% | 147 | 115 | $4K | |
| 85060 | <1% | 54 | 43 | $717.58 | |
| 88189 | <1% | 15 | 14 | $573.43 | |
| 88188 | <1% | 15 | 12 | $427.10 | |
| 88302 | <1% | 39 | 37 | $323.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCURRY, MICHAEL (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Curry Orthopedics and Sports Medicine PLLC | Ada, OK | $229K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.